2025-09-04T08:46:24-05:00 2024-12-31 521392008 GELMAN ROSENBERG & FREEDMAN 4550 MONTGOMERY AVE SUITE 800N BETHESDA MD 208142930 990 2024-01-01 271538205 USAGAINSTALZHEIMER'S ACTION USAG 2024105199 5614 CONNECTICUT AVE NW 288 WASHINGTON DC 20015 RUSSELL PAULSEN COO 2024105199 2025-09-04 1 0 ELIZABETH W HELLER P00397829 3019519090 2024 2025-03-06 01:10:19Z RUSSELL PAULSEN 5614 CONNECTICUT AVE NW 288 WASHINGTON DC 20015 426395 0 X WWW.USAGAINSTALZHEIMERSACTION.ORG X 2009 DC SEE PART III, LINE 1. 3 3 0 4 0 0 500721 415535 0 0 8854 10860 0 0 509575 426395 0 0 0 0 81163 31253 0 0 11527 328133 367780 409296 399033 100279 27362 352981 378878 32688 31224 320293 347654 X USAGAINSTALZHEIMER'S ACTION IS A RELENTLESS ADVOCACY FORCE COMMITTED TO ENDING ALZHEIMER'S DISEASE. WE PRESS FOR GREATER URGENCY FROM GOVERNMENT, INDUSTRY, AND THE SCIENTIFIC COMMUNITY IN THE DRIVE FOR EFFECTIVE TREATMENTS, PREVENTION, AND ULTIMATELY A CURE. WE ACCOMPLISH THIS THROUGH DETERMINED LEADERSHIP, COLLABORATIVE ADVOCACY, AND STRATEGIC INVESTMENTS. 0 0 337720 SINCE OUR FOUNDING IN 2010, USAGAINSTALZHEIMER'S ACTION HAS WORKED WITH PEOPLE AND ORGANIZATIONS ACROSS SECTORS TO ACHIEVE MILESTONES, INCLUDING:-SECURING REAUTHORIZATION OF THE NATIONAL ALZHEIMER'S PROJECT ACT (NAPA) AND THE ALZHEIMER'S ACCOUNTABILITY AND INVESTMENT ACT (AAIA), STRENGTHENING THE NATIONAL PLAN TO ADVANCE RESEARCH, SUPPORT CAREGIVERS, AND ADDRESS ALZHEIMER'S AS A PUBLIC HEALTH PRIORITY.- INCREASING FEDERAL INVESTMENT IN ALZHEIMER'S RESEARCH. USAGAINSTALZHEIMER'S ACTION PLAYED A KEY ROLE IN THE $100 MILLION INCREASE IN THE FY 2024 BUDGET FOR AD/ADRD RESEARCH AT THE NATIONAL INSTITUTES OF HEALTH (NIH). AS A RESPECTED ADVOCATE, USAGAINSTALZHEIMER'S ACTION HAS HELPED (CONTINUED ON SCHEDULE O)DRIVE INCREASES IN NIH AD/ADRD SPENDING FROM YEARLY AVERAGES OF $400 MILLION A DECADE EARLIER TO NEARLY $3.86 BILLION IN FY2024.- SUPPORTING BIPARTISAN REINTRODUCTION OF THE CHANGE ACT, (CONCENTRATING ON HIGH-VALUE ALZHEIMER'S NEEDS TO GET TO AN END), A MAJOR STEP TOWARD IMPROVING EARLY DETECTION, DIAGNOSIS, AND TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DEMENTIAS.- WORKING AGGRESSIVELY THROUGH ADVERTISING AND GRASSROOTS CAMPAIGNS TO SECURE MEDICARE COVERAGE FOR NEW ALZHEIMER'S TREATMENTS, ENSURING BROADER ACCESS TO MEDICATIONS AND DIAGNOSTIC SCANS. 337720 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 3 0 1 0 0 0 0 0 1 1 0 0 0 X 3 3 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 AL AR CA FL GA HI IL KS KY MD MA MI MN MS NH NJ MN NY NC OR PA RI SC TN UT VA WV WI X RUSSELL PAULSEN 2024105199 5614 CONNECTICUT AVE NW 288 WASHINGTON DC 20015 X X GEORGE VRADENBURG CHAIRMAN 2.00 X X 0 0 0 JILL LESSER SECRETARY & TREASURER 1.00 X X 0 0 0 NANCY ZIRKIN BOARD MEMBER 1.00 X 0 0 0 RUSSELL PAULSEN COO (SEE SCHEDULE O) 1.00 X 0 0 0 0 0 0 0 0 0 0 ALSTON & BIRD LLP ONE ATLANTIC CENTER 1201 W PEACHTR ATLANTA GA 30309 LOBBYING AND POLICY WORK 144074 1 415535 415535 10860 10860 426395 0 0 10860 10345 9311 1034 17547 1010 16537 922 117 805 600 217 383 1839 666 1173 17726 17726 276956 276956 8744 4327 4417 1688 1425 214 49 46695 43405 2679 611 4407 4407 STATE REGISTRATION FEES 10865 10865 PAYROLL FEES 632 229 403 MISCELLANEOUS 67 57 8 2 399033 337720 49786 11527 352976 351878 5 27000 352981 378878 32688 31224 32688 31224 X 320293 347654 320293 347654 352981 378878 27362 0 X 0 1 X 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 WAS PREPARED BY THE OUTSIDE ACCOUNTANTS AND REVIEWED BY ONE OF THE DIRECTORS AND THE CHIEF FINANCIAL OFFICER. A COPY OF THE FORM 990 WAS PROVIDED TO EACH MEMBER OF THE ORGANIZATION'S GOVERNING BODY BEFORE IT WAS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C EACH DIRECTOR, PRINCIPAL OFFICER AND MEMBER OF A COMMITTEE WITH GOVERNING BOARD DELEGATED POWERS ANNUALLY SIGNS A STATEMENT WHICH AFFIRMS THAT HE/SHE: A. HAS RECEIVED A COPY OF THE CONFLICTS OF INTEREST POLICY, B. HAS READ AND UNDERSTANDS THE POLICY, C. HAS AGREED TO COMPLY WITH THE POLICY, AND D. UNDERSTANDS THAT THE ORGANIZATION IS A NON-PROFIT PUBLIC BENEFIT CORPORATION AND, IN ORDER TO MAINTAIN ITS FEDERAL TAX EXEMPTION, IT MUST ENGAGE PRIMARILY IN ACTIVITIES WHICH ACCOMPLISH ONE OR MORE OF ITS TAX-EXEMPT PURPOSES. IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF THE FINANCIAL INTEREST AND BE GIVEN THE OPPORTUNITY TO DISCLOSE ALL MATERIAL FACTS TO THE DIRECTORS AND MEMBERS OF COMMITTEES WITH GOVERNING BOARD DELEGATED POWERS CONSIDERING THE PROPOSED TRANSACTION OR ARRANGEMENT. AFTER DISCLOSURE OF THE FINANCIAL INTEREST AND ALL MATERIAL FACTS, AND AFTER ANY DISCUSSION WITH THE INTERESTED PERSON, HE/SHE LEAVES THE GOVERNING BOARD OR COMMITTEE MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON. THE REMAINING BOARD OR COMMITTEE MEMBERS DECIDE IF A CONFLICT OF INTEREST EXISTS. FORM 990, PART VI, SECTION C, LINE 19 USAGAINSTALZHEIMER'S ACTION DOES NOT REGULARLY PUBLISH ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, OR FINANCIAL STATEMENTS. HOWEVER, THE ORGANIZATION MAKES SUCH DOCUMENTS AVAILABLE, IF A REQUEST IS MADE BY A MEMBER OF THE PUBLIC. FORM 990, PART VII, LINE 1: USAGAINSTALZHEIMER'S ACTION (USA2ACTION) AND USAGAINSTALZHEIMER'S (USA2), AN UNRELATED ORGANIZATION FOR TAX PURPOSES, HAVE ENTERED INTO A COST-SHARING ARRANGEMENT UNDER WHICH USA2ACTION REIMBURSES USA2 FOR USA2ACTION'S ALLOCABLE SHARE OF THE COMPENSATION OF CERTAIN EMPLOYEES FOR SERVICES PROVIDED TO USA2ACTION. PURSUANT TO THIS AGREEMENT, USA2ACTION REIMBURSED USA2 FOR ITS SHARE OF OFFICER COMPENSATION AS FOLLOWS: RUSSELL PAULSEN: $10,345